GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Monsenso AS (OCSE:MONSO) » Definitions » EBIT

Monsenso AS (OCSE:MONSO) EBIT : kr-5.84 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Monsenso AS EBIT?

Monsenso AS's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was kr-3.46 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-5.84 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Monsenso AS's annualized ROC % for the quarter that ended in Jun. 2024 was -34.02%. Monsenso AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -4,265.43%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Monsenso AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -62.43%.

Monsenso AS EBIT Historical Data

The historical data trend for Monsenso AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monsenso AS EBIT Chart

Monsenso AS Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial 0.17 -5.87 -9.02 -8.82 -5.79

Monsenso AS Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.25 -3.57 -3.40 -2.39 -3.46

Competitive Comparison of Monsenso AS's EBIT

For the Health Information Services subindustry, Monsenso AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Monsenso AS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Monsenso AS's EV-to-EBIT falls into.


Monsenso AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-5.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monsenso AS  (OCSE:MONSO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Monsenso AS's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-6.968 * ( 1 - 6.97% )/( (21.011 + 17.103)/ 2 )
=-6.4823304/19.057
=-34.02 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18.886 - 0.668 - ( 1.812 - max(0, 7.477 - 4.684+1.812))
=21.011

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21.882 - 0.247 - ( 5.971 - max(0, 4.365 - 8.897+5.971))
=17.103

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Monsenso AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.91/( ( (0.213 + max(-4.643, 0)) + (0.111 + max(-1.46, 0)) )/ 2 )
=-6.91/( ( 0.213 + 0.111 )/ 2 )
=-6.91/0.162
=-4,265.43 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.113 + 0 + 0.721) - (0.668 + 0 + 6.809)
=-4.643

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.983 + 0 + 0.922) - (0.247 + 0 + 4.118)
=-1.46

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Monsenso AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-5.841/9.356
=-62.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monsenso AS EBIT Related Terms

Thank you for viewing the detailed overview of Monsenso AS's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Monsenso AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Monsenso AS (OCSE:MONSO) » Definitions » EBIT
Comparable Companies
OCSE:BRAINP GEHC VEEV ASX:PME DOCS SOLV TEM HQY TSE:2413 WAY HKSE:02228 SZSE:300253 NSE:IKS BTSG PRVA HKSE:01833 HKSE:02587 NSE:SAGILITY HKSE:02506 CERT
Traded in Other Exchanges
N/A
Address
Rosenorns Alle 31, 2, Frederiksberg, DNK, DK-1970
Website
https://www.monsenso.com
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. Its mHealth solution for mental health consists of three components, namely A smartphone app for individuals, A web portal for clinicians & users, and A smartphone app for carers.

Monsenso AS Headlines

No Headlines